In BCC, we observed no expression of ASIC2 in 56%, and 44% revealed a weak expression (Figure 2b,f and Figure 5b, Supplementary Figures S4–S7 second column, Figure S16). The gene discussed is ASIC2; the disease is skin basal cell carcinoma.